Hudson Bay Capital Management LP 13D and 13G filings for Cyclacel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-04 4:03 pm Unchanged |
2021-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Hudson Bay Capital Management LP | 27,500 3.970% |
0 (Unchanged) |
Filing |
| 2021-02-09 2:28 pm Purchase |
2020-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Hudson Bay Capital Management LP | 27,500 7.160% |
27,500 (New Position) |
Filing |